Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
Funding Opportunity PAR-24-168 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to reissue PAR-24-256 "Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)" in order to support proof-of-concept feasibility trials guided by the NIH Music-based Interventions (MBI) Toolkit for research on brain disorders of aging. These early stage clinical trials will generate evidence supporting the validity of the NIH MBI Toolkits guiding principles as well as the necessary pilot data to assess the feasibility of...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 10, 2024 Category: Research Source Type: funding
Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in ARIA (U24 - Clinical Trials Not Allowed)
Funding Opportunity RFA-NS-24-034 from the NIH Guide for Grants and Contracts. The purpose of this Alzheimers Disease-Related Dementia (ADRD) initiative is to promote the development and distribution of innovative technologies, methods, protocols, and biomedical materials that enhance combined human neuropathology and neuroimaging research with data aimed at understanding the underlying pathophysiology of in vivo imaging results typically associated with vascular contributions to cognitive impairment and dementia (VCID) in TBI-related dementia and other ADRD diagnoses. Resources developed under this FOA must follow open...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2024 Category: Research Source Type: funding
Notice of Change to Letter of Intent Due Date(s) Information Listed in RFA-AG-24-001, Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)
Notice NOT-AG-24-014 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2024 Category: Research Source Type: funding
Notice of Pre-Application Webinar for RFA-AG-25-005: Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trial Not Allowed)
Notice NOT-AG-24-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-121 from the NIH Guide for Grants and Contracts. The specific purpose of this NOFO is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary trainin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 13, 2024 Category: Research Source Type: funding
Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
Funding Opportunity RFA-AG-25-002 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for a U54 Specialized Center (henceforth: Consortium) to provide resources, expertise, and coordination to advance innovative, high-quality research on palliative care for those with serious illness across the lifespan. This research infrastructure will encompass Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD), cancer, and other serious illnesses and populations relevant to the partnering Institutes, Centers, and Offices (ICOs). NIH currently funds many palli...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 21, 2024 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements for NIA-VA Mentored Physician and Clinical Psychologist Scientist Award in Alzheimers Disease (AD) and AD-Related Dementias (ADRD)
Notice NOT-AG-23-054 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 20, 2024 Category: Research Source Type: funding
Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)
Funding Opportunity RFA-NS-24-032 from the NIH Guide for Grants and Contracts. This NOFO would support development and validation of novel clinically- and/or pathophysiologically-relevant human cellular models of ADRD. The cellular model systems would be expected to capture the multi-faceted pathologies and multiple cell types observed in ADRDs. Validation includes internal, face, construct, and predictive (to the extent possible) validation. These models can be developed/validated with the goal of supporting therapy development or better understanding of human disease mechanisms and mechanisms that uncover predispositi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 16, 2024 Category: Research Source Type: funding
Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trail Not Allowed)
Funding Opportunity RFA-AG-25-005 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites U24 Cooperative Agreement applications that propose to establish a national Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials. The Network will serve as a centralized hub for developing, validating, standardizing, and disseminating measures and measurement methods for AD/ADRD primary prevention trials. It will incorporate measures and measurement methods across neuropsychological, biomarker, and func...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 13, 2024 Category: Research Source Type: funding
Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-25-016 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to invite applications proposing to establish multi-scale computational models recapitulating dynamic changes associated with aging and Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). This broad scope encompasses a variety of computational approachessuch as mathematical and computational modeling, image analysis, artificial intelligence, and machine learningto better understand aging processes and AD/ADRD across molecules, cells and networks, and cognition and behavior. (Source...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 6, 2024 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed)
Notice NOT-AG-23-080 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 1, 2024 Category: Research Source Type: funding
Notice of Intent to Publish a Notice of Funding Opportunity for Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trial Not Allowed)
Notice NOT-AG-23-061 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 30, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trial Optional)
Notice NOT-AG-23-061 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 29, 2023 Category: Research Source Type: funding
Notice of Pre-Application Webinar for NOT-AG-23-060, "Notice of Special Interest (NOSI): Telehealth for People and Families Living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)"
Notice NOT-AG-23-073 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 29, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Telehealth for People and Families Living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD)
Notice of Special Interest for research to (1) determine the impact of telehealth on cost, access, quality, timeliness, and equity of care for people and families living with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and (2) identify telehealth care delivery methods that work well for people and families living with AD/ADRD. Geographic coverage: Nationwide -- National Institute on Aging, National Institutes of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - November 21, 2023 Category: American Health Source Type: funding
